Kadirvelraj, Renuka http://orcid.org/0000-0003-1473-0023
Boruah, Bhargavi M.
Wang, Shuo
Chapla, Digantkumar
Huang, Chin
Ramiah, Annapoorani
Hudson, Kieran L. http://orcid.org/0000-0002-3566-7003
Prudden, Anthony R.
Boons, Geert-Jan http://orcid.org/0000-0003-3111-5954
Withers, Stephen G. http://orcid.org/0000-0002-6722-5701
Wood, Zachary A. http://orcid.org/0000-0002-7251-0822
Moremen, Kelley W. http://orcid.org/0000-0003-1768-582X
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R01GM130915, P41GM103390, P01GM107012, T32GM1007004, S10RR25528, S10RR028976, S10OD021762, R01GM130915, R01GM130915, P01GM107012, R01GM130915, R01GM130915, T32GM1007004, R01GM130915, P01GM107012, P01GM107012, R01GM130915)
Canadian Institutes of Health Research
Article History
Received: 26 July 2022
Accepted: 20 April 2023
First Online: 18 May 2023
Competing interests
: K.W.M. is the President of Glyco Expression Technologies, a biotechnology spinout that focuses on production and commercialization of recombinant glycosyltransferases, which could conceivably profit from the results described herein. The remaining authors have no competing interests.